| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 38 | 2016 | 248 | 3.970 |
Why?
|
| Dopamine Uptake Inhibitors | 14 | 2016 | 81 | 2.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 16 | 2019 | 82 | 1.820 |
Why?
|
| Cocaine-Related Disorders | 11 | 2013 | 99 | 1.380 |
Why?
|
| Progesterone | 20 | 2010 | 120 | 1.350 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 6 | 2016 | 133 | 1.190 |
Why?
|
| Rats, Inbred F344 | 35 | 2016 | 256 | 1.120 |
Why?
|
| Sex Characteristics | 13 | 2013 | 253 | 1.100 |
Why?
|
| Corpus Striatum | 5 | 2019 | 119 | 1.050 |
Why?
|
| Rats | 60 | 2019 | 3701 | 1.050 |
Why?
|
| Caudate Nucleus | 5 | 2019 | 22 | 0.880 |
Why?
|
| Interleukin-6 | 6 | 2015 | 165 | 0.740 |
Why?
|
| Putamen | 4 | 2016 | 16 | 0.730 |
Why?
|
| Signal Transduction | 7 | 2016 | 2111 | 0.710 |
Why?
|
| Estrogens | 12 | 2015 | 202 | 0.680 |
Why?
|
| Receptors, Opioid, delta | 10 | 1999 | 22 | 0.680 |
Why?
|
| Animals | 73 | 2019 | 16695 | 0.660 |
Why?
|
| RNA, Messenger | 23 | 2010 | 1265 | 0.640 |
Why?
|
| Memory | 2 | 2019 | 175 | 0.610 |
Why?
|
| Protein Precursors | 5 | 2003 | 59 | 0.570 |
Why?
|
| Gene Expression Regulation | 8 | 2005 | 1066 | 0.550 |
Why?
|
| Nucleus Accumbens | 7 | 2019 | 99 | 0.550 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2014 | 98 | 0.540 |
Why?
|
| Behavior, Animal | 14 | 2016 | 369 | 0.520 |
Why?
|
| Methamphetamine | 1 | 2019 | 167 | 0.520 |
Why?
|
| Receptors, Dopamine D1 | 4 | 2010 | 45 | 0.510 |
Why?
|
| Conditioning, Classical | 1 | 2016 | 67 | 0.490 |
Why?
|
| Motor Activity | 14 | 2016 | 438 | 0.490 |
Why?
|
| Excitatory Amino Acid Antagonists | 7 | 2016 | 93 | 0.480 |
Why?
|
| Dizocilpine Maleate | 4 | 2016 | 43 | 0.480 |
Why?
|
| Receptors, Opioid, mu | 5 | 2002 | 50 | 0.470 |
Why?
|
| Sertoli Cells | 4 | 2000 | 42 | 0.460 |
Why?
|
| Trans-Activators | 4 | 2002 | 190 | 0.450 |
Why?
|
| Dopamine | 3 | 2019 | 272 | 0.450 |
Why?
|
| Down-Regulation | 1 | 2016 | 452 | 0.440 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 5 | 2016 | 74 | 0.440 |
Why?
|
| Estradiol | 9 | 2015 | 269 | 0.430 |
Why?
|
| DNA-Binding Proteins | 6 | 2006 | 557 | 0.430 |
Why?
|
| Locomotion | 6 | 2016 | 104 | 0.420 |
Why?
|
| Phosphorylation | 9 | 2014 | 973 | 0.420 |
Why?
|
| Interferon-gamma | 3 | 2002 | 268 | 0.420 |
Why?
|
| Male | 48 | 2019 | 22779 | 0.410 |
Why?
|
| Brain | 9 | 2013 | 1452 | 0.410 |
Why?
|
| Dynorphins | 2 | 2003 | 17 | 0.400 |
Why?
|
| Testosterone | 6 | 2010 | 211 | 0.390 |
Why?
|
| Ovariectomy | 16 | 2019 | 128 | 0.390 |
Why?
|
| Gonadal Hormones | 1 | 2012 | 5 | 0.370 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 3 | 2009 | 6 | 0.370 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2014 | 52 | 0.360 |
Why?
|
| Estrous Cycle | 4 | 2009 | 37 | 0.340 |
Why?
|
| Central Nervous System | 4 | 2002 | 150 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 20 | 2019 | 1737 | 0.340 |
Why?
|
| Lymphokines | 2 | 2002 | 17 | 0.340 |
Why?
|
| Growth Inhibitors | 2 | 2002 | 29 | 0.330 |
Why?
|
| Astrocytes | 2 | 2002 | 244 | 0.330 |
Why?
|
| Transcription Factor AP-1 | 2 | 2002 | 31 | 0.330 |
Why?
|
| Up-Regulation | 6 | 2008 | 534 | 0.320 |
Why?
|
| Blotting, Western | 8 | 2013 | 884 | 0.320 |
Why?
|
| Pain | 7 | 2015 | 283 | 0.310 |
Why?
|
| Time Factors | 9 | 2016 | 1848 | 0.300 |
Why?
|
| Transcription, Genetic | 5 | 1998 | 599 | 0.290 |
Why?
|
| Endocrine System | 3 | 2003 | 12 | 0.280 |
Why?
|
| Spinal Cord | 7 | 2015 | 109 | 0.260 |
Why?
|
| Sex Factors | 7 | 2019 | 1008 | 0.250 |
Why?
|
| Corticosterone | 10 | 2010 | 89 | 0.240 |
Why?
|
| Cyclic AMP | 2 | 1997 | 135 | 0.240 |
Why?
|
| Female | 40 | 2019 | 24018 | 0.240 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2002 | 53 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 136 | 0.230 |
Why?
|
| Anesthetics, Local | 2 | 2003 | 20 | 0.220 |
Why?
|
| Enkephalins | 5 | 1998 | 29 | 0.220 |
Why?
|
| Genes, Immediate-Early | 2 | 2008 | 11 | 0.210 |
Why?
|
| Genes, fos | 3 | 1998 | 14 | 0.210 |
Why?
|
| Ethanol | 2 | 1997 | 221 | 0.210 |
Why?
|
| Neurons | 3 | 2003 | 1246 | 0.210 |
Why?
|
| Cerebral Cortex | 2 | 2002 | 303 | 0.210 |
Why?
|
| Central Nervous System Stimulants | 2 | 2019 | 181 | 0.190 |
Why?
|
| RNA | 2 | 2002 | 266 | 0.190 |
Why?
|
| Neostriatum | 1 | 2002 | 28 | 0.190 |
Why?
|
| Estrus | 2 | 2001 | 14 | 0.190 |
Why?
|
| Tretinoin | 1 | 2002 | 50 | 0.180 |
Why?
|
| Glioma | 1 | 2002 | 92 | 0.180 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2000 | 22 | 0.170 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2011 | 43 | 0.170 |
Why?
|
| Drug Administration Schedule | 7 | 2006 | 153 | 0.160 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2015 | 55 | 0.160 |
Why?
|
| Formaldehyde | 5 | 2015 | 30 | 0.160 |
Why?
|
| Dinoprostone | 2 | 2010 | 69 | 0.160 |
Why?
|
| Naltrexone | 2 | 1998 | 34 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2008 | 1112 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 382 | 0.150 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 59 | 0.150 |
Why?
|
| Drug Interactions | 5 | 2006 | 151 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 4 | 2002 | 35 | 0.150 |
Why?
|
| Substantia Nigra | 1 | 2019 | 49 | 0.150 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2019 | 88 | 0.150 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2019 | 37 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 152 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 4 | 2002 | 97 | 0.140 |
Why?
|
| Pituitary-Adrenal System | 2 | 2015 | 41 | 0.130 |
Why?
|
| Dopamine Antagonists | 2 | 2008 | 48 | 0.130 |
Why?
|
| Oligopeptides | 3 | 1998 | 108 | 0.130 |
Why?
|
| Sirtuin 2 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Testis | 1 | 1998 | 203 | 0.130 |
Why?
|
| CREB-Binding Protein | 1 | 2016 | 13 | 0.130 |
Why?
|
| N-Methylaspartate | 2 | 2009 | 58 | 0.130 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 33 | 0.130 |
Why?
|
| Globus Pallidus | 1 | 2016 | 20 | 0.130 |
Why?
|
| Blotting, Northern | 5 | 1997 | 149 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2002 | 979 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 4 | 2002 | 506 | 0.120 |
Why?
|
| Dexamethasone | 1 | 1995 | 55 | 0.110 |
Why?
|
| Naloxone | 1 | 1994 | 56 | 0.110 |
Why?
|
| Ganglia, Spinal | 1 | 2015 | 41 | 0.110 |
Why?
|
| Nociceptors | 2 | 2011 | 29 | 0.110 |
Why?
|
| Behavior | 2 | 2003 | 34 | 0.100 |
Why?
|
| Models, Animal | 2 | 2012 | 149 | 0.100 |
Why?
|
| Stereotyped Behavior | 5 | 2008 | 23 | 0.100 |
Why?
|
| Hyperalgesia | 2 | 2011 | 23 | 0.100 |
Why?
|
| Plasmids | 2 | 1995 | 247 | 0.100 |
Why?
|
| Prosencephalon | 3 | 1997 | 34 | 0.100 |
Why?
|
| Conditioning, Operant | 1 | 2013 | 90 | 0.100 |
Why?
|
| Disease Models, Animal | 5 | 2011 | 1554 | 0.100 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2010 | 83 | 0.100 |
Why?
|
| Transcription Factors | 1 | 1996 | 722 | 0.090 |
Why?
|
| Inflammation | 3 | 2015 | 729 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2003 | 126 | 0.090 |
Why?
|
| DNA | 3 | 2002 | 594 | 0.090 |
Why?
|
| Cytokines | 1 | 2015 | 661 | 0.090 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2002 | 6 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2002 | 1617 | 0.080 |
Why?
|
| Tamoxifen | 2 | 2008 | 67 | 0.080 |
Why?
|
| Progestins | 1 | 2010 | 12 | 0.080 |
Why?
|
| Binding Sites | 3 | 2003 | 670 | 0.080 |
Why?
|
| Quinpirole | 1 | 2010 | 18 | 0.080 |
Why?
|
| Dopamine Agonists | 1 | 2010 | 34 | 0.080 |
Why?
|
| Receptors, Progesterone | 2 | 2008 | 90 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 147 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 58 | 0.080 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2009 | 45 | 0.080 |
Why?
|
| Memory, Short-Term | 1 | 2010 | 56 | 0.080 |
Why?
|
| DNA, Circular | 1 | 1989 | 8 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 128 | 0.080 |
Why?
|
| Salicylamides | 2 | 2005 | 13 | 0.080 |
Why?
|
| Simian virus 40 | 1 | 1989 | 38 | 0.080 |
Why?
|
| Tubulin | 1 | 2009 | 94 | 0.070 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2008 | 6 | 0.070 |
Why?
|
| Reward | 3 | 2007 | 106 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2009 | 135 | 0.070 |
Why?
|
| DNA Replication | 1 | 1989 | 153 | 0.070 |
Why?
|
| Pregnanolone | 1 | 2008 | 4 | 0.070 |
Why?
|
| Hormone Antagonists | 1 | 2008 | 13 | 0.070 |
Why?
|
| Analgesics, Opioid | 2 | 2002 | 245 | 0.070 |
Why?
|
| Mifepristone | 1 | 2008 | 34 | 0.070 |
Why?
|
| Transfection | 1 | 1989 | 526 | 0.070 |
Why?
|
| Neuroblastoma | 2 | 2002 | 134 | 0.070 |
Why?
|
| Genistein | 2 | 1998 | 43 | 0.070 |
Why?
|
| DNA, Viral | 1 | 1989 | 323 | 0.070 |
Why?
|
| Mice | 10 | 2003 | 6490 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2003 | 350 | 0.070 |
Why?
|
| Biogenic Monoamines | 2 | 2004 | 32 | 0.070 |
Why?
|
| Pain Measurement | 4 | 2010 | 181 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1997 | 40 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2005 | 53 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 54 | 0.060 |
Why?
|
| Pain Threshold | 1 | 2005 | 34 | 0.060 |
Why?
|
| Benzazepines | 1 | 2005 | 33 | 0.060 |
Why?
|
| Morphine | 2 | 2003 | 68 | 0.060 |
Why?
|
| Analysis of Variance | 4 | 2008 | 574 | 0.060 |
Why?
|
| Posterior Horn Cells | 1 | 2003 | 3 | 0.050 |
Why?
|
| Dextromethorphan | 1 | 2003 | 3 | 0.050 |
Why?
|
| Morphine Dependence | 1 | 2003 | 23 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 457 | 0.050 |
Why?
|
| Gene Expression | 2 | 2003 | 692 | 0.050 |
Why?
|
| Exploratory Behavior | 3 | 2010 | 78 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2011 | 189 | 0.050 |
Why?
|
| Hormones | 1 | 2002 | 56 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2002 | 74 | 0.050 |
Why?
|
| In Situ Hybridization | 6 | 1997 | 134 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2002 | 928 | 0.050 |
Why?
|
| Isoquinolines | 1 | 2002 | 50 | 0.050 |
Why?
|
| Gonads | 1 | 2001 | 21 | 0.040 |
Why?
|
| Receptors, Opioid | 1 | 2001 | 40 | 0.040 |
Why?
|
| Dactinomycin | 1 | 2000 | 11 | 0.040 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 6 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 20 | 0.040 |
Why?
|
| Leydig Cells | 1 | 2000 | 10 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2000 | 30 | 0.040 |
Why?
|
| Base Sequence | 3 | 1997 | 997 | 0.040 |
Why?
|
| Adrenalectomy | 2 | 2015 | 23 | 0.040 |
Why?
|
| Humans | 4 | 2012 | 42163 | 0.040 |
Why?
|
| Drug Tolerance | 2 | 2016 | 26 | 0.040 |
Why?
|
| Ovary | 2 | 1996 | 112 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2002 | 633 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 649 | 0.040 |
Why?
|
| Receptors, OSM-LIF | 1 | 1998 | 1 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1998 | 1 | 0.040 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1998 | 7 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 1998 | 11 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1995 | 71 | 0.040 |
Why?
|
| Reaction Time | 3 | 2006 | 151 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 1998 | 78 | 0.030 |
Why?
|
| Genes, jun | 1 | 1997 | 7 | 0.030 |
Why?
|
| Analgesics | 1 | 1998 | 55 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 1997 | 23 | 0.030 |
Why?
|
| Threonine | 1 | 1997 | 24 | 0.030 |
Why?
|
| Serine | 1 | 1997 | 81 | 0.030 |
Why?
|
| Receptors, Oxytocin | 1 | 1997 | 9 | 0.030 |
Why?
|
| Tyrosine | 1 | 1997 | 119 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 1997 | 60 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 1996 | 15 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1998 | 159 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2016 | 9 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 52 | 0.030 |
Why?
|
| Uterus | 1 | 1997 | 57 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1997 | 173 | 0.030 |
Why?
|
| Receptors, LHRH | 1 | 1996 | 3 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 2010 | 107 | 0.030 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1996 | 12 | 0.030 |
Why?
|
| Phosphotransferases | 1 | 2016 | 35 | 0.030 |
Why?
|
| Isoflavones | 1 | 1997 | 132 | 0.030 |
Why?
|
| Spermatozoa | 1 | 1998 | 208 | 0.030 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 1996 | 6 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 1996 | 9 | 0.030 |
Why?
|
| Enkephalin, Methionine | 1 | 1995 | 7 | 0.030 |
Why?
|
| Nerve Endings | 1 | 1995 | 8 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 2008 | 70 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 2 | 2008 | 58 | 0.030 |
Why?
|
| Castration | 2 | 2008 | 34 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 62 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1995 | 22 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1995 | 34 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 1995 | 54 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 522 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 318 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1994 | 20 | 0.030 |
Why?
|
| Axons | 1 | 1995 | 116 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 1994 | 25 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 2 | 2006 | 49 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 1996 | 383 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 74 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2015 | 86 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 1996 | 330 | 0.030 |
Why?
|
| Models, Molecular | 1 | 1997 | 875 | 0.030 |
Why?
|
| Acute Disease | 2 | 2003 | 156 | 0.030 |
Why?
|
| Injections, Intraventricular | 3 | 1998 | 59 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 228 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 379 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 534 | 0.020 |
Why?
|
| Mice, Inbred Strains | 3 | 1997 | 116 | 0.020 |
Why?
|
| Irritants | 1 | 2011 | 8 | 0.020 |
Why?
|
| Carrageenan | 1 | 2011 | 15 | 0.020 |
Why?
|
| Sesame Oil | 1 | 2010 | 2 | 0.020 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2010 | 7 | 0.020 |
Why?
|
| Autoradiography | 1 | 2010 | 35 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2010 | 13 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 462 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 42 | 0.020 |
Why?
|
| Motor Skills | 1 | 2010 | 45 | 0.020 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2009 | 8 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2010 | 106 | 0.020 |
Why?
|
| Haplorhini | 1 | 1989 | 23 | 0.020 |
Why?
|
| Camptothecin | 1 | 1989 | 24 | 0.020 |
Why?
|
| Sexual Behavior, Animal | 2 | 2002 | 64 | 0.020 |
Why?
|
| Calcineurin | 1 | 2008 | 22 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 209 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1989 | 96 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 1995 | 1559 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1989 | 156 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2008 | 70 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2010 | 160 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2010 | 318 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 36 | 0.020 |
Why?
|
| Recurrence | 1 | 2007 | 149 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2007 | 77 | 0.020 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 2 | 1998 | 5 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 281 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 37 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 66 | 0.020 |
Why?
|
| Learning | 1 | 2007 | 155 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 548 | 0.020 |
Why?
|
| Cognition | 1 | 2010 | 458 | 0.020 |
Why?
|
| Analgesia | 1 | 2005 | 11 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2005 | 29 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 113 | 0.010 |
Why?
|
| Cell Line | 1 | 1989 | 1416 | 0.010 |
Why?
|
| RNA Probes | 2 | 1995 | 11 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 21 | 0.010 |
Why?
|
| Dependovirus | 1 | 2003 | 16 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 2003 | 14 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 85 | 0.010 |
Why?
|
| Integrases | 1 | 2003 | 29 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 80 | 0.010 |
Why?
|
| Receptors, AMPA | 1 | 2003 | 57 | 0.010 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2003 | 80 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 165 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2003 | 228 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 1188 | 0.010 |
Why?
|
| Ventral Tegmental Area | 1 | 2003 | 47 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2003 | 63 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 156 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 196 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 458 | 0.010 |
Why?
|
| Periaqueductal Gray | 1 | 1997 | 11 | 0.010 |
Why?
|
| Thalamus | 1 | 1997 | 34 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1997 | 58 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1997 | 141 | 0.010 |
Why?
|
| Hypothalamus, Middle | 1 | 1997 | 4 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 1737 | 0.010 |
Why?
|
| Pentobarbital | 1 | 1996 | 2 | 0.010 |
Why?
|
| Chloral Hydrate | 1 | 1996 | 2 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 774 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 21 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 279 | 0.010 |
Why?
|
| Amygdala | 1 | 1997 | 125 | 0.010 |
Why?
|
| Immune Sera | 1 | 1995 | 56 | 0.010 |
Why?
|
| Neck | 1 | 1995 | 20 | 0.010 |
Why?
|
| Dendrites | 1 | 1995 | 57 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1995 | 111 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1996 | 282 | 0.010 |
Why?
|
| Drug Stability | 1 | 1995 | 127 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 230 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 207 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 454 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 195 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1996 | 658 | 0.010 |
Why?
|
| Linear Models | 1 | 1995 | 311 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1995 | 301 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1995 | 301 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1995 | 602 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 1058 | 0.010 |
Why?
|